ScripArtificial intelligence-focused biotech Isomorphic Labs is getting another big infusion of funding to further develop its drug-design system and also to advance some of its programs into the clinic, o
ScripVertex remains bullish on prospects for developing curative, endogenous insulin-sparing cell therapies for type 1 diabetes, despite disappointing results unveiled on 28 March that led the Boston-based
ScripNovo Nordisk has just presented two successful cardiovascular-focused Phase III studies of semaglutide, but analysts think they will not be enough to stop Eli Lilly’s rival, tirzepatide, from dominati
In VivoPfizer was the biggest company in the world by pharmaceutical sales in 2024. Among the rest of the top five there was change, however, as Merck & Co climbed above Johnson & Johnson and AbbVie